Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study

OBJECTIVES: To estimate vaccine effectiveness after the first and second dose of ChAdOx1 nCoV-19 against symptomatic COVID-19 and infection in a socially vulnerable community in Brazil when Gamma and Delta were the predominant variants circulating. METHODS: We conducted a test-negative study in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ranzani, Otavio T., Silva, Amanda A.B., Peres, Igor T., Antunes, Bianca B.P., Gonzaga-da-Silva, Thiago W., Soranz, Daniel R., Cerbino-Neto, José, Hamacher, Silvio, Bozza, Fernando A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828302/
https://www.ncbi.nlm.nih.gov/pubmed/35150884
http://dx.doi.org/10.1016/j.cmi.2022.01.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828302/
https://www.ncbi.nlm.nih.gov/pubmed/35150884
http://dx.doi.org/10.1016/j.cmi.2022.01.032

Ejemplares similares